Table 2.

Development of CVD events and other complications over the 11-year period among the study subjects.

Presence of complications and comorbid conditions	% [95% CI]
CVD events	6 [3.1–9]
Other microvascular complications	20.9 [15.9–26]
Hypertension and/or dyslipidemia	59.4 [53.3–65.5]